mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara

Continued innovation and investment is vital to maintaining the
U.S.'s leadership in the biopharma sector. Rob and Jackie sit
down with Andrew Geall, Chief Development Officer at Replicate
Bioscience, and Deborah Barbara, strategic advisor to Primrose
Bio, to discuss the development and potential of mRNA as the
fourth pillar of pharmaceutical innovation.
Mentioned

Sandra Barbosu, “Harnessing AI to Accelerate Innovation in
the Biopharmaceutical Industry,” (ITIF, November 2024)

 Richard Fleischer, dir. Fantastic Voyage, (20th
Century-Fox, 1966).

Related

Stephen Ezell and Meghan Ostertag, “The Bayh-Dole Act’s Role
in Stimulating University-Led Regional Economic Growth,” (ITIF,
June 2025)